SBFM - Sunshine Biopharma reports 1H results
- Sunshine Biopharma press release ( NASDAQ: SBFM ): 1H Revenue of $0.27M.
- The Company had a net loss of $1,775,106 in the first half of 2022, compared to a net loss of $9,064,180 in the first half of 2021.
For further details see:
Sunshine Biopharma reports 1H results